Search Results - "Barybin, A. E."

Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety by Mironov, N. Yu, Yuricheva, Yu. A., Vlodzyanovskiy, V. V., Sokolov, S. F., Dzaurova, Kh. M., Golitsyn, S. P., Shubik, Yu. V., Berman, M. V., Medvedev, M. M., Rivin, A. E., Parkhomchuk, D. S., Barybin, A. E., Balandin, D. А., Batalov, R. E., Terekhov, D. V., Evstifeev, I. V., Kildeev, I. R., Pyataeva, O. V., Zenin, S. A.

“…Aim. We aimed to assess safety and effectiveness of class III antiarrhythmic drug Refralon for conversion of atrial fibrillation (AFib) and flutter (AFl) in…”
Get full text

Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectiveness by Mironov, N. Yu, Yuricheva, Yu. A., Vlodzyanovskiy, V. V., Sokolov, S. F., Dzaurova, Kh. M., Golitsyn, S. P., Shubik, Yu. V., Berman, M. V., Medvedev, M. M., Rivin, A. E., Parkhomchuk, D. S., Barybin, A. E., Balandin, D. А., Batalov, R. E., Terekhov, D. S., Evstifeev, I. V., Kildeev, I. R., Pyataeva, O. V., Zenin, S. A.

“…Aim. We aimed to assess safety and effectiveness of class III antiarrhythmic drug Refralon for conversion of atrial fibrillation (AFib) and flutter (AFl) in…”
Get full text